It is often used as an initial screening tool for suspected multiple myeloma or related plasma cell disorders before more detailed quantitative testing.

Certainly, it may reveal abnormal proteins early, but additional blood tests and bone marrow studies are needed for confirmation.

Yes, dehydration can concentrate urine, potentially increase protein detection and affect interpretation.

Yes, repeated testing can show whether abnormal proteins decrease with therapy, helping track treatment response.

Rarely, other proteins may mimic Bence Jones proteins, so confirmatory tests are often required.

Yes, kidney impairment can increase protein excretion, complicating interpretation of results.